List View Detail View 476-500 of 582 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 19 20 21 ... 24 Next Product Clone Appl. Reg Cat# Size Price Quantity See more size options for this product on the previous page. PE anti-human CD162 Antibody KPL-1 FC RUO 328806 100 tests 262 CHF PE/Dazzle™ 594 anti-human CD162 Antibody KPL-1 FC RUO 328820 100 tests 317 CHF PE/Cyanine7 anti-human CD162 Antibody KPL-1 FC RUO 328815 25 tests 153 CHF 328816 100 tests 323 CHF PerCP/Cyanine5.5 anti-human CD162 Antibody KPL-1 FC RUO 328817 25 tests 129 CHF 328818 100 tests 347 CHF Purified anti-human CD162 Antibody KPL-1 FC, IHC-P, IHC-F, IP, WB RUO 328802 100 µg 119 CHF TotalSeq™-A0871 anti-human CD162 Antibody KPL-1 PG RUO 328821 10 µg 369 CHF TotalSeq™-B0871 anti-human CD162 Antibody KPL-1 PG RUO 328823 10 µg 369 CHF TotalSeq™-C0871 anti-human CD162 Antibody KPL-1 PG RUO 328825 10 µg 369 CHF Brilliant Violet 421™ anti-human CD162 Antibody KPL-1 FC, IHC-P RUO 328807 25 µg 193 CHF 328808 100 µg 402 CHF FITC anti-rat CD161 Recombinant Antibody QA19A15 FC RUO 251103 25 µg 80 CHF 251104 100 µg 175 CHF Purified anti-rat CD161 Recombinant Antibody QA19A15 FC RUO 251102 100 µg 124 CHF Alexa Fluor® 647 anti-human CD163 Recombinant Antibody QA19A16 FC, IHC-P RUO 364305 25 tests 112 CHF 364306 100 tests 305 CHF Purified anti-human CD163 Recombinant Antibody QA19A16 FC, IHC-P, SB RUO 364302 100 µg 118 CHF Alexa Fluor® 594 anti-human CD163 Recombinant Antibody QA19A16 IHC-P RUO 364303 25 µg 147 CHF 364304 100 µg 352 CHF TotalSeq™-Bn1307 anti-human CD163 Recombinant Antibody QA19A16 SB RUO 364307 10 µg 369 CHF PE anti-mouse CD169 (Siglec-1) Recombinant Antibody QA20A47 FC RUO 138903 25 µg 145 CHF 138904 100 µg 365 CHF Purified anti-mouse CD169 (Siglec-1) Recombinant Antibody QA20A47 FC RUO 138902 100 µg 235 CHF PE anti-mouse CD163 Recombinant Antibody QA20A94 FC RUO 111803 25 µg 141 CHF See more size options for this product on the next page. Results Per Page: 25 50 100 200 Previous 1 ... 19 20 21 ... 24 Next
Follow Us